Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

MetricSTESterisZBHZimmer BiometRMDResMed
Snapshot
Price$200.40$87.09$188.45
Market cap$19.75B$17.28B$27.36B
Valuation
P/E25.3x22.4x18x
Forward P/E19.8x26.2x15.5x
Growth
Revenue growth8.7%9.2%10.3%
EPS growth27.9%-14.6%16.5%
Profitability
Net margin13.2%9.1%27.4%
ROE11.1%6.0%24.4%
Balance sheet & cash
Debt / equity0.27x0.59x0.11x
Free cash flow yield5.4%7.5%3.8%
Dividend yield1.2%1.0%1.2%
Verdict
Investment ratingFavorable· 59Neutral· 50Strong· 75

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearSTEtoday $200ZBHtoday $87RMDtoday $188
2027$192.31 – $282.05+41% CAGR$66.62 – $97.71+12% CAGR$164.62 – $241.44+28% CAGR
2028$246.06 – $360.89+34% CAGR$67.96 – $99.67+7% CAGR$191.73 – $281.20+22% CAGR
2029$314.83 – $461.75+32% CAGR$69.32 – $101.66+5% CAGR$223.31 – $327.51+20% CAGR
2030$402.83 – $590.82+31% CAGR$70.70 – $103.70+4% CAGR$260.08 – $381.46+19% CAGR
2031$515.42 – $755.95+30% CAGR$72.12 – $105.77+4% CAGR$302.92 – $444.28+19% CAGR
5-yr CAGR20.8% – 30.4%-3.7% – 4.0%10.0% – 18.7%